Table 5.

Incidences of auras that were followed by headache prior to galcanezumab treatment

	Incidence %
AURA	All patients	Responders	Non responders	Fisher exact
visual auraa	30.4	29.6	31.6	1.000
sensory aurab	21.7	18.5	26.3	0.718
speech aurac	8.7	7.4	10.5	1.000

^avisual aura was determined when participants described experiencing zigzag lines, scintillation, scintillating scotoma, hemianopsia, fortification spectra, flickering lights, flashes of bright light, blind spots, c-shaped zigzag lines – All at least 20 min before onset of headache

^bSensory aura was determined when participants described experiencing tingling, numbness, or paresthesia in their fingers, hands, face, or legs

^cSpeech aura was determined when participants described having trouble with word-finding difficulty or speech production